Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Draegerwerk AG & Co. KGaA (DRW3) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:DRW3Draegerwerk AG & Co. KGaACHF 105.20CHF 1.65B12.2876.81%Moderate BuyUnlock the CH:DRW3 analyst price target with TipRanks PremiumCH:DRW3Unlock the CH:DRW3 top-analyst price target with TipRanks Premium
DE:AFXCarl Zeiss MeditecEUR 35.00EUR 3.08B20.62-19.76%Moderate SellUnlock the DE:AFX analyst price target with TipRanks PremiumCH:DRW3 vs DE:AFXUnlock the DE:AFX top-analyst price target with TipRanks Premium
DE:COPCompuGroup MedicalEUR 28.20EUR 1.50B43.4217.30%―Unlock the DE:COP analyst price target with TipRanks PremiumCH:DRW3 vs DE:COPUnlock the DE:COP top-analyst price target with TipRanks Premium
DE:EUZEckert & Ziegler Strahlen und MedizintechnikEUR 15.34EUR 871.66M18.13-8.96%Moderate BuyUnlock the DE:EUZ analyst price target with TipRanks PremiumCH:DRW3 vs DE:EUZUnlock the DE:EUZ top-analyst price target with TipRanks Premium
DE:SBSSTRATEC BiomedicalEUR 27.90EUR 317.88M-668.7531.29%Moderate BuyUnlock the DE:SBS analyst price target with TipRanks PremiumCH:DRW3 vs DE:SBSUnlock the DE:SBS top-analyst price target with TipRanks Premium
DE:SHLSiemens Healthineers AGEUR 43.95EUR 48.56B22.121.45%Moderate BuyUnlock the DE:SHL analyst price target with TipRanks PremiumCH:DRW3 vs DE:SHLUnlock the DE:SHL top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:DRW3Draegerwerk AG & Co. KGaA105.2045.7076.81%
DE:AFXCarl Zeiss Meditec35.00-6.74-16.15%
DE:COPCompuGroup Medical28.205.0621.85%
DE:EUZEckert & Ziegler Strahlen und Medizintechnik15.34-0.70-4.36%
DE:SBSSTRATEC Biomedical27.907.2635.20%
DE:SHLSiemens Healthineers AG43.951.112.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts